Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial
Arthritis & Rheumatology, an official journal of the American College of Rheumatology, is a peer-reviewed rheumatology journal of the rheumatic diseases.